Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 13 of the 29 sources its claims cite were checked for support.
Abstract
In many cells and specially in muscle, mitochondria form elongated filaments or a branched reticulum. We show that Mfn2 (mitofusin 2), a mitochondrial membrane protein that participates in mitochondrial fusion in mammalian cells, is induced during myogenesis and contributes to the maintenance and operation of the mitochondrial network. Repression of Mfn2 caused morphological and functional fragmentation of the mitochondrial network into independent clusters. Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak. We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression. In all, our data indicate that Mfn2 expression is crucial in mitochondrial metabolism through the maintenance of the mitochondrial network architecture, and reduced Mfn2 expression may explain some of the metabolic alterations associated with obesity.
Overview
CoChat Summary
TL;DR
Mitofusin-2 (Mfn2), a mitochondrial membrane protein induced during myogenesis, is required to maintain the elongated, intralumenally connected mitochondrial network in muscle cells and to sustain mitochondrial metabolism. Mfn2 expression is reduced in skeletal muscle of obese Zucker rats and obese humans, suggesting its loss contributes to the metabolic alterations of obesity.
Key findings
- Mfn2 mRNA (4.7 kb) is predominant in skeletal muscle and heart, and Mfn2 mRNA and protein are markedly induced during L6E9 myoblast differentiation into myotubes, in parallel with development of an extensive mitochondrial network.
- Antisense repression of Mfn2 in L6E9 myotubes (≈50% reduction in mitochondrial extracts) fragmented the network: 82% of mitochondrial filaments were longer than 5 µm in control cells versus only 22% in antisense cells. Laser microirradiation showed loss of membrane potential spread across the whole network in controls but only a very reduced extension in antisense myotubes.
- Mfn2 repression reduced mitochondrial function: glucose oxidation fell by 30% in myotubes and by 30% (or 70% per the Discussion) in 10T1/2 antisense clones; mitochondrial membrane potential fell by nearly 60%; oxygen consumption fell 30%, with coupled respiration unchanged and proton-leak-linked respiration significantly reduced.
- In obesity, Mfn2 mRNA was 34% lower in Zucker obese rats and 36% lower in obese humans; Mfn2 protein was 39% lower (rats) and 43% lower (humans). Obese rat muscle showed higher mitochondrial density (11.2 ± 0.6 vs 8.2 ± 0.5 organelles/10 µm², p < 0.001), 42% greater total mitochondrial surface area, and 25% lower volume per unit area, consistent with a smaller, fragmented network.
Methods
- Differential screening by PCR-select cDNA subtraction on gastrocnemius muscle from obese (fa/fa) versus lean (fa/+) Zucker rats isolated the 321-bp C31 clone, identified as Mfn2; expression was confirmed by Northern blot, competitive-quantitative RT-PCR, and Western blot with an anti-Mfn2 peptide antibody.
- Human samples: vastus lateralis biopsies from 13 healthy lean volunteers (51 ± 2 years; BMI 23 ± 1 kg/m²; insulin 34 ± 2 pmol/liter) and 9 obese volunteers (46 ± 2 years; BMI 34 ± 1 kg/m²; insulin 62 ± 6 pmol/liter), taken before a 3-h euglycemic hyperinsulinemic clamp (insulin 12 pmol/kg/min); obese subjects showed 50% lower insulin-stimulated glucose disposal (4.9 ± 0.8 vs 10.1 ± 1.1 mg/kg/min).
- Functional work used transient Mfn2 overexpression and antisense knockdown (stable transfection in 10T1/2 fibroblasts; adenoviral antisense in L6E9 myotubes), with confocal immunofluorescence/MitoTracker/JC-1 imaging, laser microirradiation, electron microscopy, [¹⁴C]glucose oxidation, and Clark-electrode respiration measurements; mitochondrial volume/surface area in soleus muscle was quantified by the vertical sections stereological method (4 obese and 4 lean rats, 80 photographs/group at 5,000×).
Limitations
- The paper states that further studies in rodents after recombinant ablation of Mfn2 are required to determine whether it contributes to obesity, and it notes that the mechanism by which Mfn2 supports respiratory chain activity is only postulated (destabilization/reduced activity of certain complexes), not demonstrated.
- The authors note that not all L6E9 myoblasts differentiate in culture (≈30% remain undifferentiated) and that undifferentiated myoblasts are not infected by adenovirus, so the observed reduction in glucose oxidation after antisense infection is a substantial underestimate of the actual inhibition.
- Evident from the text: the human data are cross-sectional and correlational (n = 13 lean, 9 obese), so causality between reduced Mfn2 and obesity-related metabolic alterations is not established; the mitochondrial network/morphology measurements in obesity were made only in Zucker rats, not in human muscle.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 0 Not valid · 8 Not checked · 69 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We also show that the Mfn2-dependent mechanism of mitochondrial control is disturbed in obesity by reduced Mfn2 expression.”
- Also stated in: § Abstract · plain
“We also show that this regulatory mechanism is disturbed in obesity.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Concomitantly, repression of Mfn2 reduced glucose oxidation, mitochondrial membrane potential, cell respiration, and mitochondrial proton leak.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In myoblast cells, a short portion of a mitochondrial filament became de-energized when one of the cluster-composing mitochondria was damaged by laser (Fig. 3,C and D). As a consequence of the loss of mitochondrial membrane potential, mitochondria became unstained by JC-1.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Under these conditions, we found that myogenesis caused the induction of Mfn2 protein in L6E9 cells (Fig. 2C).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
41 more claims
Create a free account to see all 84 claims and every source verdict.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 27
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its role in mitochondrial fusion, Mfn2 has been described to be involved in the regulation of cell proliferation, oxidative metabolism, autophagy, mitophagy, mitochondrial antiviral signaling, and unfolded protein response (Bach et al, 2003; Chen et al, 2004; Yasukawa et al, 2009; Hailey et al, 2010; Ngoh et al, 2012; Zhao et al, 2012; Chen & Dorn, 2013; Munoz et al, 2013).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lipid overloading promotes fast and transient changes in mitochondrial architecture.”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In line with the above observations, obese patients display a largely fragmented mitochondrial network in skeletal muscle (Bach et al, 2003).”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Bach et al, 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mfn2 is a nuclear-encoded mitochondrial protein that shows homology with Drosophila or yeast Fzo proteins (26,27) and is highly expressed in skeletal muscle, the heart, and the brain (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and mitochondria from obese Zucker rats show higher mitochondrial surface, lower mitochondrial volume, and a lower extent of the mitochondrial network (23).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [23]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ RESULTS
“Repression of Mfn2 in 10T1/2 cells also reduced glucose oxidation by 307 (Fig. 8C).”
§ DISCUSSION
“cellular repression of Mfn2 in 10T1/2 cells (687 reduction) reduces mitochondrial proton leak and cellular oxygen consumption (307 reduction) and glucose oxidation (707 reduction)”
Citations
Cites
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Delettre, C., Lenaers, G., Griffoin, J.-M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., et al. (2000) · Nature Genetics · doi:10.1038/79936 · Cited by 1,446
Alexander, C., Votruba, M., Pesch, U. E. A., Thiselton, D. L., Mayer, S., Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., et al. (2000) · Nature Genetics · doi:10.1038/79944 · Cited by 1,330
Estimation of surface area from vertical sections
Baddeley, A. J., Gundersen, H. J. G., & Cruz‐Orive, L. M. (1986) · Journal of Microscopy · doi:10.1111/j.1365-2818.1986.tb04282.x · Cited by 1,058
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Control of mitochondrial morphology by a human mitofusin
Santel, A., & Fuller, M. T. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.867 · Cited by 1,012
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
A Human Dynamin-related Protein Controls the Distribution of Mitochondria
Smirnova, E., Shurland, D.-L., Ryazantsev, S. N., & van der Bliek, A. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.351 · Cited by 733
Research works printed but not linked: 3
- Astrup, 1987, Int. J. Obesity, 11, 51
- Kaplan, 1991, Int. J. Obesity, 15, 809
- Buchberger, 1996, Am. J. Physiol., 271, R472
Cited by
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
Liesa, M., & Shirihai, O. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.002 · Cited by 1,341
“An accompanying decrease in Mfn2 expression provided a potential mechanism to the reduction in mitochondrial size (Bach et al., 2003; Bach et al., 2005).”
BackgroundMitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306
“Interestingly, deletion of hepatic MFN2 signi fi cantly promotes in fl ammatory responses, accumulation of triglycerides, fi brosis, and HCC in mouse models of NASH, whereas restoring MFN2 expression using adenovirus in mutant (liver-speci fi c) mice lacking MFN2 observably alleviate disease symptoms of NASH.”
BackgroundMitochondrial dynamics and apoptosis
Suen, D.-F., Norris, K. L., & Youle, R. J. (2008) · Genes & Development · doi:10.1101/gad.1658508 · Cited by 1,270
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS
Nisoli, E., Tonello, C., Cardile, A., Cozzi, V., Bracale, R., Tedesco, L., Falcone, S., Valerio, A., Cantoni, O., Clementi, E., et al. (2005) · Science · doi:10.1126/science.1117728 · Cited by 1,107
Adipose tissue and insulin resistance in obese
Ahmed, B., Sultana, R., & Greene, M. W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111315 · Cited by 1,047
Mitochondrial fragmentation in neurodegeneration.
Knott, A. B., Perkins, G., Schwarzenbacher, R., & Bossy-Wetzel, E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2417 · Cited by 1,002
“, and increased levels of MFN2 in developing muscle tissue correlates with more efficient mitochondrial function and energy transmission frm the cell periphery to the cell cor”
Mitochondrial Dynamics in Mammalian Health and Disease
Liesa, M., Palacín, M., & Zorzano, A. (2009) · Physiological Reviews · doi:10.1152/physrev.00030.2008 · Cited by 953
“In these conditions, coupled oxygen consumption is unaltered, whereas respiration linked to the mitochondrial proton leak is significantly reduced in antisense cells (16).”
BackgroundInfluentialSelf-citationTranscriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932
“Mitofusins are highly expressed in heart and skeletal muscle, and their expression is induced during myogenesis and physical exercise.(6,7) In addition to the control of the mitochondrial network, Mfn2 also stimulates the mitochondrial oxidation of substrates, cell respiration, and mitochondrial membrane potential, su…”
BackgroundCellular and molecular mechanisms of mitochondrial function
Osellame, L. D., Blacker, T. S., & Duchen, M. R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.05.003 · Cited by 873
“50,51 Mice lacking either Mfn1 or Mfn2 die midgestation while embryonic stem cell lines derived from mice lack any detectable fusion activity highlighting the severity of the deletions.”
BackgroundReactive oxygen species in health and disease
Alfadda, A. A., & Sallam, R. M. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/936486 · Cited by 824
“As an example, reduced expression of mitofusin 2 (Mfn2), one of the mitochondrial proteins responsible for its dynamic morphology, was demonstrated to be partly responsible for decreased glucose oxidation and cell respiration in obesity [49].”
BackgroundBonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.-A., Morio, B., Vidal, H., & Rieusset, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32601 · Cited by 819
“This observation is in agreement with previous reports in other models of obesity and diabetes and also in humans (22).”
ResultSelf-citationGlobal Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review
Clemente-Suárez, V. J., Beltrán-Velasco, A. I., Redondo-Flórez, L., Martín-Rodríguez, A., & Tornero-Aguilera, J. F. (2023) · Nutrients · doi:10.3390/nu15122749 · Cited by 804
The Molecular Bases of Training Adaptation
Coffey, V. G., & Hawley, J. A. (2007) · Sports Medicine · doi:10.2165/00007256-200737090-00001 · Cited by 756
“proteins have been strongly implicated (Bach et al. 2003; Santel et al. 2003).”
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
“These processes depend on certain proteins, including two isoforms of mitofusin (MFN) involved in docking to initiate fusion and the presenillin-associated rhomboid-like (PARL) protein important for morphologic integrity (63).”
Sebastián, D., Hernández-Alvarez, M. I., Segalés, J., Sorianello, E., Muñoz, J. P., Sala, D., Waget, A., Liesa, M., Paz, J. C., Gopalacharyulu, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108220109 · Cited by 673
Self-citationPGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“Indeed, reduced Mfn2 expression was described in obese type 2 diabetic patients, leading to functional and morphological fragmentation of the mitochondrial network [175].”
BackgroundBravo, R., Vicencio, J. M., Parra, V., Troncoso, R., Munoz, J. P., Bui, M., Quiroga, C., Rodriguez, A. E., Verdejo, H. E., Ferreira, J., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.080762 · Cited by 605
“Ca2+ allosterically increases the activity of matrix dehydrogenases required for mitochondrial respiration and promotes ATP production by disinhibition of the ATP synthase (Brown, 1992; Balaban, 2009).”
BackgroundSelf-citationRedox regulation of mitochondrial function
Handy, D. E., & Loscalzo, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4123 · Cited by 588
“It is believed that alterations in mitochondrial fusion and fission may serve functional purposes to respond to oxygen and metabolic fluctuations (24, 446).”
BackgroundMitochondrial-nuclear communications
Ryan, M. T., & Hoogenraad, N. J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052305.091720 · Cited by 575
Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus
Shenouda, S. M., Widlansky, M. E., Chen, K., Xu, G., Holbrook, M., Tabit, C. E., Hamburg, N. M., Frame, A. A., Caiano, T. L., Kluge, M. A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.014506 · Cited by 570
Perry, C. G. R., Lally, J., Holloway, G. P., Heigenhauser, G. J. F., Bonen, A., & Spriet, L. L. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.199448 · Cited by 559
“Importantly, fragmented mitochondria appear to possess lower maximal capacities to oxidize carbohydrates and fatty acids (Bach et al. 2003; Pich et al. 2005).”
BackgroundThe role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551
Emerging functions of mammalian mitochondrial fusion and fission
Chen, H., & Chan, D. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi270 · Cited by 538
“A screen of differentially expressed genes from skeletal muscle of obese rats identified Mfn2 as a suppressor of obesity (61).”
BackgroundMitochondrial dysfunction and insulin resistance: an update
Montgomery, M. K., & Turner, N. (2015) · Endocrine Connections · doi:10.1530/ec-14-0092 · Cited by 527
“Silencing of MFN2 in myotubes leads to decreased oxygen consumption and glucose oxidation (103, 104), with a simultaneous decrease in glucose incorporation into glycogen, as well as reductions in pyruvate and palmitate oxidation in myotubes (104).”
New insights into the role of mitochondria in aging: mitochondrial dynamics and more
Seo, A. Y., Joseph, A.-M., Dutta, D., Hwang, J. C. Y., Aris, J. P., & Leeuwenburgh, C. (2010) · Journal of Cell Science · doi:10.1242/jcs.070490 · Cited by 522
“Repression of Mfn2 in cells decreases oxygen consumption, glucose oxidation, mitochondrial membrane potential and the expression of oxidative phosphorylation proteins (Bach et al., 2003; Chen et al., 2005; Pich et al., 2005).”
BackgroundMitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance
Schneeberger, M., Dietrich, M. O., Sebastián, D., Imbernón, M., Castaño, C., Garcia, A., Esteban, Y., Gonzalez-Franquesa, A., Rodríguez, I. C., Bortolozzi, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.003 · Cited by 519
Mitofusins, from Mitochondria to Metabolism
Schrepfer, E., & Scorrano, L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.022 · Cited by 495
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
Nisoli, E., Falcone, S., Tonello, C., Cozzi, V., Palomba, L., Fiorani, M., Pisconti, A., Brunelli, S., Cardile, A., Francolini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405432101 · Cited by 495
Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake
Merz, K. E., & Thurmond, D. C. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190029 · Cited by 494
“High-fat diet causes mitochondrial dysfunction, decreases mitochondrial number in human skeletal muscle (23, 200, 254), changes the mitochondrial structure, and reduces oxidative phosphorylation and mitochondrial respiration (15, 44).”
Mitochondrial Dysfunction in Cancer
Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 489
“Consistent with a critical role for mitochondrial fusion in regulating metabolism, inactivation of Mitofusin 1, Mitofusin 2, or Opa-1 inhibits oxidative metabolism and cell growth (68, 69).”
BackgroundAcquirement of brown fat cell features by human white adipocytes
Tiraby, C., Tavernier, G., Lefort, C., Larrouy, D., Bouillaud, F., Ricquier, D., & Langin, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305235200 · Cited by 474
The role of mitochondria in NLRP3 inflammasome activation
Liu, Q., Zhang, D., Hu, D., Zhou, X., & Zhou, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.010 · Cited by 475
Pich, S., Bach, D., Briones, P., Liesa, M., Camps, M., Testar, X., Palacín, M., & Zorzano, A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi149 · Cited by 455
“In contrast, overexpression of Fzo or mitofusins causes perinuclear clustering of mitochondria (8,11,12) and co-expression of Mfn2 and a dominant negative mutant of Drp1 leads to the generation of mitochondrial tubules (8).”
BackgroundMethodResultSelf-citationMfn2 modulates the UPR and mitochondrial function via repression of PERK
Muñoz, J. P., Ivanova, S., Sánchez‐Wandelmer, J., Martínez‐Cristóbal, P., Noguera, E., Sancho, A., Díaz‐Ramos, A., Hernández‐Alvarez, M. I., Sebastián, D., Mauvezin, C., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.168 · Cited by 451
“On the basis of the mitochondrial fusion activity of Mfn2, the alterations in mitochondrial morphology and function detected upon silencing or ablation of this gene have been attributed to reduced mitochondrial fusion (Bach et al , 2003; Chen et al , 2003; Pich et al , 2005).”
Self-citationThe Mitochondrial Basis of Aging and Age-Related Disorders
Srivastava, S. (2017) · Genes · doi:10.3390/genes8120398 · Cited by 420
“Reduced expression of Mfn1 and/or Mfn2 in skeletal muscle has been linked to obesity and type 2 diabetes mellitus in both rodents and humans [81,89,90].”
BackgroundSebastián, D., Sorianello, E., Segalés, J., Irazoki, A., Ruiz‐Bonilla, V., Sala, D., Planet, E., Berenguer‐Llergo, A., Muñoz, J. P., Sánchez‐Feutrie, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593084 · Cited by 396
Self-citationMitofusins 1/2 and ERRα expression are increased in human skeletal muscle after physical exercise
Cartoni, R., Léger, B., Hock, M. B., Praz, M., Crettenand, A., Pich, S., Ziltener, J., Luthi, F., Dériaz, O., Zorzano, A., et al. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.092031 · Cited by 406
“Skeletal muscle mitochondria from insulin resistant obese compared with healthy subjects also demonstrates a reduced gene and protein expression of mitofusin-2 (Mfn2), a key player involved in the formation and maintenance of the mitochondrial network (Bach et al. 2003).”
BackgroundMethodInfluentialSelf-citationDeficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease
Hernández-Alvarez, M. I., Sebastián, D., Vives, S., Ivanova, S., Bartoccioni, P., Kakimoto, P., Plana, N., Veiga, S. R., Hernández, V., Vasconcelos, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.010 · Cited by 400
“, 2016), and its depletion causes ER stress and plays a relevant role in the maintenance of mitochondrial metabolism, insulin signaling, and energy homeostasis (Bach et al., 2003; Pich et al., 2005; Muñoz et al., 2013; Schneeberger et al., 2013; Sebastián et al., 2012).”
Self-citationGanglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network
Niemann, A., Ruegg, M., La Padula, V., Schenone, A., & Suter, U. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507087 · Cited by 401
“derstood poorly, it is obvious that complex and divergent stimuli influence the mitochondrial appearance (Goglia et al., 1999; Bach et al., 2003; Bossy-Wetzel et al., 2003; Honda and Hirose, 2003).”
BackgroundMitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology
Zhan, M., Brooks, C., Liu, F., Sun, L., & Dong, Z. (2013) · Kidney International · doi:10.1038/ki.2012.441 · Cited by 397
Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle
Bach, D., Naon, D., Pich, S., Soriano, F. X., Vega, N., Rieusset, J., Laville, M., Guillet, C., Boirie, Y., Wallberg-Henriksson, H., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2685 · Cited by 369
Self-citationMollica, M. P., Mattace Raso, G., Cavaliere, G., Trinchese, G., De Filippo, C., Aceto, S., Prisco, M., Pirozzi, C., Di Guida, F., Lama, A., et al. (2017) · Diabetes · doi:10.2337/db16-0924 · Cited by 356
“(52) consistently demonstrated a decreased mitochondrial proton leak and increased bioenergetics efficiency in Mfn2-depleted cells.”
BackgroundPapanicolaou, K. N., Khairallah, R. J., Ngoh, G. A., Chikando, A., Luptak, I., O'Shea, K. M., Riley, D. D., Lugus, J. J., Colucci, W. S., Lederer, W. J., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00911-10 · Cited by 358
“Mfn-2 is robustly expressed in the heart (5), and Mfn-2 insufficiency and associated fragmentation of the mitochondrial network in cultured neonatal cardiac myocytes have been reported to promote early apoptotic events (66).”
BackgroundResultMitofusin 2: from functions to disease
Filadi, R., Pendin, D., & Pizzo, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0023-6 · Cited by 356
Mitochondrial ‘kiss‐and‐run’: interplay between mitochondrial motility and fusion–fission dynamics
Liu, X., Weaver, D., Shirihai, O., & Hajnóczky, G. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.255 · Cited by 345
“Mfn2 is also involved in other functions such as control of mitochondrial metabolism (Bach et al, 2003) and tethering of mitochondria to the ER (de Brito and Scorrano, 2008).”
BackgroundDeterminants and outcomes of mitochondrial dynamics
Quintana-Cabrera, R., & Scorrano, L. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.02.012 · Cited by 347
Soriano, F. X., Liesa, M., Bach, D., Chan, D. C., Palacín, M., & Zorzano, A. (2006) · Diabetes · doi:10.2337/db05-0509 · Cited by 343
“Mitofusin 2 (Mfn2) is a mitochondrial fusion protein (16–19) that is expressed mainly in tissues with high energetic requirements, such as skeletal muscle and heart (16); consequently, it shows an expression pattern similar to that of PGC-1 .”
BackgroundMethodSelf-citationRepairing mitochondrial dysfunction in disease
Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337
Liu, Y. J., McIntyre, R. L., Janssens, G. E., & Houtkooper, R. H. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111212 · Cited by 334
“For example, in obese Zucker rats and obese humans, skeletal muscle mitochondria are smaller and fragmented, along with reduced Mfn2 expression (Bach et al., 2003).”
BackgroundInfluentialTNF- downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents
Valerio, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28570 · Cited by 327
Salabei, J. K., Gibb, A. A., & Hill, B. G. (2014) · Nature Protocols · doi:10.1038/nprot.2014.018 · Cited by 324
Mitochondrial morphology and cardiovascular disease
Ong, S.-B., & Hausenloy, D. J. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq237 · Cited by 323
“Knock-down of Mfn2 has been demonstrated to reduce mitochondrial membrane potential, lower oxygen consumption, and reduce substrate oxidation, resulting in less oxidative phosphorylation and increased dependency on anaerobic glycolysis with a higher rate of glucose uptake and a lower rate of glycogen synthesis.(33,63)…”
BackgroundSkeletal Muscle Mitochondria and Aging: A Review
Peterson, C. M., Johannsen, D. L., & Ravussin, E. (2012) · Journal of Aging Research · doi:10.1155/2012/194821 · Cited by 322
“Exercise has also been shown to increase the activity of antioxidant enzymes and heat shock proteins [228], potentially reducing ROS production and decreasing the potential for mitochondrial oxidative damage thought to occur during aging.”
BackgroundMitochondrial morphology transitions and functions: implications for retrograde signaling?
Picard, M., Shirihai, O. S., Gentil, B. J., & Burelle, Y. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00584.2012 · Cited by 319
“Other experiments have demonstrated similar decreases in cellular respiration or glucose oxidation in response to Mfn2 downregulation (6, 117).”
BackgroundThe Metabolic Theory of Pulmonary Arterial Hypertension
Paulin, R., & Michelakis, E. D. (2014) · Circulation Research · doi:10.1161/circresaha.115.301130 · Cited by 314
Menk, A. V., Scharping, N. E., Rivadeneira, D. B., Calderon, M. J., Watson, M. J., Dunstane, D., Watkins, S. C., & Delgoffe, G. M. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171068 · Cited by 313
“Indeed, mitofusin-2 is a PGC1α target gene, consistent with the hypothesis that mitochondrial biogenesis and fusion are linked (Bach et al., 2003).”
BackgroundA guide to understanding endoplasmic reticulum stress in metabolic disorders
Lemmer, I. L., Willemsen, N., Hilal, N., & Bartelt, A. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101169 · Cited by 310
“Dynamin-related protein-1 (DRP1, encoded by DNM1L) and mitofusins (MFN1 and MFN2) are found in ER-mitochondria contact sites, and MFN2 has been shown to play a prominent role in obesity and metabolism in mice and humans [13].”
BackgroundNeuspiel, M., Zunino, R., Gangaraju, S., Rippstein, P., & McBride, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501599200 · Cited by 306
Dietrich, M. O., Liu, Z.-W., & Horvath, T. L. (2013) · Cell · doi:10.1016/j.cell.2013.09.004 · Cited by 306
“Impairment of mitochondrial fusion leads to disruption of cellular energy metabolism (Bach et al., 2003; Guillet et al., 2011; Pich et al., 2005).”
Bullon, P., Newman, H. N., & Battino, M. (2014) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00455.x · Cited by 299
Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
Apostolova, N., & Victor, V. M. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5952 · Cited by 299
“Furthermore, it has been proposed that Mfn2 correlates with the proliferation of vascular smooth muscle cells (42) and with the oxidative metabolism in muscle (16).”
Mitochondrial dynamics in cell death and neurodegeneration
Cho, D.-H., Nakamura, T., & Lipton, S. A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0435-2 · Cited by 296
“Mfn1 depletion results in a more pronounced phenotype than Mfn2 [57, 62, 63].”
BackgroundMfn2 is critical for brown adipose tissue thermogenic function
Boutant, M., Kulkarni, S. S., Joffraud, M., Ratajczak, J., Valera‐Alberni, M., Combe, R., Zorzano, A., & Cantó, C. (2017) · The EMBO Journal · doi:10.15252/embj.201694914 · Cited by 293
“Mfn2 expression is ubiquitous in mammalian tissues, albeit it finds its highest expression levels in tissues enriched in mitochondria, such as heart and the brown adipose tissue (BAT) (Bach et al , 2003).”
Self-citationResveratrol induces apoptosis and inhibits adipogenesis in 3T3‐L1 adipocytes
Rayalam, S., Yang, J., Ambati, S., Della‐Fera, M. A., & Baile, C. A. (2008) · Phytotherapy Research · doi:10.1002/ptr.2503 · Cited by 294
“Mfn2 plays an important role in the maintenance of the mitochondrial network and its expression in mitochondrial fractions from skeletal muscles of obese subjects was found to be significantly lower than in their lean counterparts (Bach et al., 2003).”
BackgroundInhibition of complex I of the electron transport chain causes O2−·-mediated mitochondrial outgrowth
Koopman, W. J. H., Verkaart, S., Visch, H.-J., van der Westhuizen, F. H., Murphy, M. P., van den Heuvel, L. W. P. J., Smeitink, J. A. M., & Willems, P. H. G. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00607.2004 · Cited by 292
Mitochondrial Dynamics: Coupling Mitochondrial Fitness with Healthy Aging
Sebastián, D., Palacín, M., & Zorzano, A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.003 · Cited by 282
“For instance,Mfn2 gene and protein expression in skeletal muscle were found to be reduced in obesity as well as in T2DM in both mice and humans [33,60].”
BackgroundSelf-citationNitric oxide and mitochondrial biogenesis
Nisoli, E., & Carruba, M. O. (2006) · Journal of Cell Science · doi:10.1242/jcs.03062 · Cited by 279
“Circumstantial evidence suggests that there is an intricate structure-function relationship between mitochondrial morphology and energy-producing activity (Mannella et al., 1997; Nakada et al., 2001; Bach et al., 2003).”
BackgroundRussell, A. P., Lamon, S., Boon, H., Wada, S., Güller, I., Brown, E. L., Chibalin, A. V., Zierath, J. R., Snow, R. J., Stepto, N., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.255695 · Cited by 271
“…to influence mitochondrial biogenesis and metabolism, including NRF1 (Short et al. 2003; Kelly & Scarpulla, 2004), mitofusin-1 (MFN1) and MFN2 (Bach et al. 2003; Cartoni et al. 2005), as well as targets regulating muscle growth such as eIF4e (Koshiba et al. 2004), p70s6K (Camera et al. 2010),…”
BackgroundInfluentialSelf-citationThe Effect of Aging on Human Skeletal Muscle Mitochondrial and Intramyocellular Lipid Ultrastructure
Crane, J. D., Devries, M. C., Safdar, A., Hamadeh, M. J., & Tarnopolsky, M. A. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp179 · Cited by 262
Nicotinamide-induced Mitophagy
Jang, S.-Y., Kang, H. T., & Hwang, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363747 · Cited by 262
Recent advances into the understanding of mitochondrial fission
Elgass, K., Pakay, J., Ryan, M. T., & Palmer, C. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.002 · Cited by 263
The origin of intermuscular adipose tissue and its pathophysiological implications
Vettor, R., Milan, G., Franzin, C., Sanna, M., De Coppi, P., Rizzuto, R., & Federspil, G. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00229.2009 · Cited by 261
“Such lesions occur during cellular aging when the extensive oxidative metabolism of mitochondria increases the production of reactive oxygen species (ROS) and consequently mtDNA damage and cell death leading to organ dysfunction, as recently shown in muscles of obese Zucker rats, where a decreased level of Mfn2 was ob…”
BackgroundPicard, M., White, K., & Turnbull, D. M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01096.2012 · Cited by 260
“In the cytosol of cultured cells, including myoblasts [myogenic precursor cells (2)], mitochondria continuously undergo morphological changes on the order of seconds to minutes (36).”
BackgroundMitochondrial morphology in mitophagy and macroautophagy
Gomes, L. C., & Scorrano, L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.012 · Cited by 252
“MFN2, on the other hand, has been implicated in other cellular functions such as cell metabolism [100], cell proliferation [101] and ER-mitochondria tethering [102].”
BackgroundMitochondrial GTPase mitofusin 2 mutation in Charcot?Marie?Tooth neuropathy type 2A
Kijima, K., Numakura, C., Izumino, H., Umetsu, K., Nezu, A., Shiiki, T., Ogawa, M., Ishizaki, Y., Kitamura, T., Shozawa, Y., et al. (2005) · Human Genetics · doi:10.1007/s00439-004-1199-2 · Cited by 251
“MFN2 is localized to the outer mitochondrial membrane and regulates the mitochondrial network architecture by fusion of mitochondria (Santel and Fuller 2001; Rojo et al. 2002; Bach et al. 2003; Chen et al. 2003).”
BackgroundStructure, function, and regulation of mitofusin‐2 in health and disease
Chandhok, G., Lazarou, M., & Neumann, B. (2018) · Biological Reviews · doi:10.1111/brv.12378 · Cited by 247
“Mfn2 is a key ubiquitination target of Parkin (Matsuda et al., 2010; Nguyen, Padman & Lazarou, 2016), and Parkin mediates the expression of PGC-1α (Shin et al., 2011), which in turn controls Mfn2 expression under stress conditions (see Section IV) (Bach et al., 2003, 2005; Soriano et al., 2006).”
BackgroundInfluentialMitochondrial Energy Metabolism and Redox Signaling in Brain Aging and Neurodegeneration
Yin, F., Boveris, A., & Cadenas, E. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4774 · Cited by 247
“The suppression of Mfn2 results in a loss of mitochondrial membrane potential, reduced OXPHOS complexes expression, and decreased glucose oxidation and respiration (13, 187).”
BackgroundHigh levels of Fis1, a pro-fission mitochondrial protein, trigger autophagy
Gomes, L. C., & Scorrano, L. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.05.442 · Cited by 242
Ultrastructure of the Mitochondrion and Its Bearing on Function and Bioenergetics
Benard, G., & Rossignol, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.2000 · Cited by 241
Moore, M. P., Cunningham, R. P., Meers, G. M., Johnson, S. A., Wheeler, A. A., Ganga, R. R., Spencer, N. M., Pitt, J. B., Diaz‐Arias, A., Swi, A. I. A., et al. (2022) · Hepatology · doi:10.1002/hep.32324 · Cited by 240
“[21] Similarly, markers of hepatic mitochondrial fusion (OPA1 and MFN2) were significantly reduced with NAFL onset and worsening NASH, in line with previous studies in rodents with NAFLD.[54,55] Additionally, the inhibition of repeated fission/fusion cycles results in mitophagic arrest and the subsequent accumulation…”
ResultInfluentialChanges in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis
Parra, V., Eisner, V., Chiong, M., Criollo, A., Moraga, F., Garcia, A., Härtel, S., Jaimovich, E., Zorzano, A., Hidalgo, C., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm029 · Cited by 232
“In order to determine whether alterations in mitochondrial fusionmodify the effects of ceramides onmitochondrial fragmentation, we studied whether a decrease in Mfn2 levels altered the cellular response to ceramides.(13) Overexpression of AsMfn2 produced a 75% decrease in Mfn2 protein levels in cultured cardiomyocytes…”
BackgroundMethodInfluentialSelf-citationMitochondrial dynamics and their potential as a therapeutic target
Whitley, B. N., Engelhart, E. A., & Hoppins, S. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.06.002 · Cited by 226
Nisoli, E., Clementi, E., Carruba, M. O., & Moncada, S. (2007) · Circulation Research · doi:10.1161/01.res.0000259591.97107.6c · Cited by 227
Russell, A. P., Wada, S., Vergani, L., Hock, M. B., Lamon, S., Léger, B., Ushida, T., Cartoni, R., Wadley, G. D., Hespel, P., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.015 · Cited by 225
OPA1 Mutation and Late‐Onset Cardiomyopathy: Mitochondrial Dysfunction and mtDNA Instability
Chen, L., Liu, T., Tran, A., Lu, X., Tomilov, A. A., Davies, V., Cortopassi, G., Chiamvimonvat, N., Bers, D. M., Votruba, M., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003012 · Cited by 223
Makino, A., Scott, B. T., & Dillmann, W. H. (2010) · Diabetologia · doi:10.1007/s00125-010-1770-4 · Cited by 223
“In addition, MFN2 was identified as a suppressor of obesity [27, 28] and hypertension [25].”
Mitofusins 1 and 2 Are Essential for Postnatal Metabolic Remodeling in Heart
Papanicolaou, K. N., Kikuchi, R., Ngoh, G. A., Coughlan, K. A., Dominguez, I., Stanley, W. C., & Walsh, K. (2012) · Circulation Research · doi:10.1161/circresaha.112.274142 · Cited by 221
Parra, V., Verdejo, H. E., Iglewski, M., del Campo, A., Troncoso, R., Jones, D., Zhu, Y., Kuzmicic, J., Pennanen, C., Lopez‑Crisosto, C., et al. (2014) · Diabetes · doi:10.2337/db13-0340 · Cited by 218
“AsMfn2 and microOpa-1 (both Ad5 serotype) generation and use was as previously described (14).”
MethodSelf-citationMitochondrial Dynamics in Diabetes
Yoon, Y., Galloway, C. A., Jhun, B. S., & Yu, T. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3286 · Cited by 215
“The reduction in Mfn2 levels was correlated with a smaller mitochondrial size and higher density, indicative of a fragmented mitochondrial network in obese Zucker rat skeletal muscle (6).”
Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes
Zorzano, A., Liesa, M., & Palacín, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.004 · Cited by 209
Self-citationCentral Role of Mitofusin 2 in Autophagosome-Lysosome Fusion in Cardiomyocytes
Zhao, T., Huang, X., Han, L., Wang, X., Cheng, H., Zhao, Y., Chen, Q., Chen, J., Cheng, H., Xiao, R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.379164 · Cited by 208
Mitochondrial dysfunction in diabetic cardiomyopathy
Duncan, J. G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.014 · Cited by 208
“Mitofusin 2, an important regulator of mitochondrial fusion, was reduced in skeletal muscle of obese ZDF rats [118].”
BackgroundRyan, J. J., & Archer, S. L. (2015) · Circulation · doi:10.1161/circulationaha.114.006979 · Cited by 205
“For example, in skeletal muscle cells, decreases in mitofusin-2 reduce glucose oxidation and oxygen consumption.(24) In myotubes, decreases in mitofusin-2 similarly reduce the oxidation of pyruvate, palmitate, and glucose.”
Mitochondrial Dynamics in Cardiovascular Health and Disease
Ong, S.-B., Hall, A. R., & Hausenloy, D. J. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4777 · Cited by 207
“At the time of its initial discovery as a mammalian mitochondrial fusion protein in 2001, it had been independently discovered in muscle from Zucker obese rats (named mitochondrial assembly regulatory factor or MARF) (6), and in vascular smooth muscle cells of rats with genetic hypertension (named hyperplasia suppress…”
InfluentialMitochondrial fusion proteins: Dual regulators of morphology and metabolism
Zorzano, A., Liesa, M., Sebastián, D., Segalés, J., & Palacín, M. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.01.002 · Cited by 196
Self-citationKoopman, W. J. H., Visch, H.-J., Verkaart, S., van den Heuvel, L. W. P. J., Smeitink, J. A. M., & Willems, P. H. G. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00104.2005 · Cited by 196
“These responses involve changes in structural architecture of the mitochondrial network (4, 22), which are generally accompanied by changes in mitochondrial content, ultrastructure, and enzyme levels (40).”
PGC1α-mediated Mitofusin-2 Deficiency in Female Rats and Humans with Pulmonary Arterial Hypertension
Ryan, J. J., Marsboom, G., Fang, Y.-H., Toth, P. T., Morrow, E., Luo, N., Piao, L., Hong, Z., Ericson, K., Zhang, H. J., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1687oc · Cited by 195
Garnier, A., Fortin, D., Zoll, J., N'Guessan, B., Mettauer, B., Lampert, E., Veksler, V., & Ventura-Clapier, R. (2005) · The FASEB Journal · doi:10.1096/fj.04-2173com · Cited by 195
“Recent data suggest that proteins that participate in mitochondrial dynamics may be relevant to mitochondrial function in allowing exchanges of soluble matrix proteins and modulating mitochondrial size and morphology (31, 44).”
Background
Metadata
- Authors
- Bach, D., Pich, S., Soriano, F. X., Vega, N., Baumgartner, B., Oriola, J., Daugaard, J. R., Lloberas, J., Camps, M., Zierath, J. R., Rabasa-Lhoret, R., Wallberg-Henriksson, H., Laville, M., Palacı́n, M., Vidal, H., Rivera, F., Brand, M., & Zorzano, A.
- Affiliations
- Parc Científic de Barcelona (ES)
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
- Karolinska University Hospital (SE)
- Inserm (FR)
- MRC Mitochondrial Biology Unit (GB)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 19
- Pages
- 17190-17197
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2127806759
- Cited by
- 832
- References
- 50
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 28 · 2023: 49 · 2022: 32 · 2021: 40 · 2020: 63 · 2019: 45 · 2018: 52 · 2017: 45 · 2016: 48 · 2015: 32 · 2014: 47 · 2013: 49 · 2012: 54
- FWCI
- 6.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6378 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- mitofusin 2, mitochondrial fusion, mitochondrial metabolism, myogenesis, muscle mitochondria, mitochondrial fragmentation, glucose oxidation, mitochondrial membrane potential, cellular respiration, mitochondrial proton leak, obesity, mitochondrial membrane proteins
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Membrane Potentials, Membrane Proteins, Middle Aged, Mitochondria, Muscle, Obesity, Rats, Zucker, Muscle, Skeletal, GTP Phosphohydrolases, Mitochondrial Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-03, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-03 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.